Officer received an award of 7,405 BIIB derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 1, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Sep 3, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000875045-26-000082
- Filed / recorded
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly Reporting personMichael Parini Officer titleChief Legal Officer SecurityRestricted Stock Unit TableDerivative (Table II) Transaction dateSep 1, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of September 1, 2026.
Around the same time
Congress tradeSits on House Ways and Means, Health3 different filers disclosed BIIB within 90 days. Disclosed 14 days after the transaction; reported as an official range, not an exact amount.
A board member of Biogen sold $121K of Biogen shares. Nobody planned it ahead of time.
A board member of Biogen sold $119K of Biogen shares. Nobody planned it ahead of time.